Scientists have found that a specific type of ovarian cancer could possibly benefit from existing platinum-based chemotherapy and new DNA repairing treatments, following better testing.
The study, led by researchers from RCSI University of Medicine and Health Sciences, is published in the Journal of the National Cancer Institute and was funded by St Luke’s Institute for Cancer Research, North East Cancer Research and Education Trust (NECRET).
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
